Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | -13.64% | -45.71% |
May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
Chart calendar Chimeric Therapeutics Limited
Upcoming events on Chimeric Therapeutics Limited
Past events on Chimeric Therapeutics Limited
2024-04-29 07:33 pm | March 2024 Sales and Revenue Release - Activities Report |
2024-03-19 06:40 pm | NWR VirtualHealthcare Conference |
2024-02-29 08:30 pm | ShareCafe Hidden Gems Webinar |
2024-02-28 04:19 pm | Q2 2024 Earnings Release |
2024-01-09 06:00 pm | Biotech Conference |
2023-11-27 07:30 pm | Business Update Call |
2023-11-13 | Annual General Meeting |
2023-10-30 07:25 pm | September 2023 Sales and Revenue Release - Activities Report |
2023-10-26 09:30 pm | ShareCafe Small Cap Hidden Gems Conference |
2023-10-22 | Business Update Call |
2023-09-28 03:54 am | Q4 2023 Earnings Release |
2023-09-13 09:00 pm | Business Update Call |
2023-09-12 | Extraordinary Shareholders Meeting |
2023-07-31 12:41 am | June 2023 Sales and Revenue Release - Activities Report |
2023-06-28 | Extraordinary Shareholders Meeting |
2023-06-03 02:15 pm | American Society of Clinical Oncology Conference - Abstract No#:418236 |
2023-05-30 | MSQ Ventures Webinar |
2023-04-28 03:13 am | March 2023 Sales and Revenue Release - Activities Report |
2023-03-23 | Wholesale Investor Emergence Conference |
2023-03-20 11:20 pm | NWR Healthcare Conference |
Annual results
Fiscal Period | June | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million AUD | Released Forecast Spread | -14,3 -12,0 -18.48% | -12,9 -15,1 14.54% | -28,5 -30,4 6.11% | -24,0 |
EBIT Million AUD | Released Forecast Spread | -15,1 -12,0 -25.51% | -13,8 -18,5 25.12% | -24,7 -24,9 1.1% | -13,3 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -15,1 -12,0 -25.54% | -14,5 -18,5 21.72% | -25,4 -24,9 -1.92% | -13,3 |
Net income Million AUD | Released Forecast Spread | -15,1 -12,0 -25.54% | -14,6 -18,5 20.84% | -25,5 -25,0 -1.86% | -13,4 |
EPS AUD | Released Forecast Spread | -0,08 -0,04 -114.79% | -0,04 -0,05 9.78% | -0,06 -0,05 -17.8% | 0,00 |
Announcement Date | 31/08/21 | 30/08/22 | 31/08/23 | - |
Quarterly results
Fiscal Period | Juni | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 S2 | 2024 S1 |
---|---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 1,55 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EPS AUD | Released Forecast Spread | -0,03 -0,04 31.25% | -0,03 -0,02 -57% | |||||
Announcement Date | 30/08/22 | 28/11/22 | 28/02/23 | 28/02/23 | - | 31/08/23 | 28/02/24 |
Past sector events for Chimeric Therapeutics Limited
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CHM Stock
- Calendar Chimeric Therapeutics Limited